Pediatric-Inspired Treatment Regimens for Adolescents and Young Adults With Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia
Stuart E. Siegel(National Coalition for Cancer Survivorship), Archie Bleyer(Oregon Health & Science University), Brandon Hayes‐Lattin(Oregon Health & Science University), Selina M. Luger(University of Pennsylvania), Bijal Shah(Boston College), Damon R. Reed(Memorial Sloan Kettering Cancer Center), Mark A. Lewis(Emory University), Rebecca H. Johnson(North Central Cancer Treatment Group), Nita L. Seibel(National Cancer Institute), Jerry J. Jaboin(Oregon Health & Science University), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Anjali S. Advani(Cleveland Clinic), David R. Freyer(University of Southern California), Peter F. Coccia(North Central Cancer Treatment Group), Lori Muffly(Stanford University), Dan Douer(Memorial Sloan Kettering Cancer Center), Wendy Stock(University of Chicago)
Cited by 168
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia
|New England Journal of Medicine|1999|1.2k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907